U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06970223) titled 'A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV' on April 11.
Brief Summary: This study will evaluate the tolerability and acceptability of injection site reactions (ISRs) of two long-acting (LA) injectables. Additional characteristics of the ISRs will be investigated and described as well as safety outcomes.
Study Start Date: April 22
Study Type: INTERVENTIONAL
Condition:
HIV Infections
Intervention:
DRUG: Cabotegravir long-acting
A single CAB LA injection administered intramuscularly.
DRUG: Lenacapavir long...